(Total Views: 117)
Posted On: 04/25/2019 2:10:40 PM
Post# of 36550
$BHC News Article - Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease https://marketwirenews.com/news-releases/sali...56322.html
(0)
(0)
My Twitter: WhyteStocks
